Deferasirox effectively removes cardiac iron in beta-thalassaemia patients with myocardial siderosis previously chelated with deferoxamine monotherapy or deferoxamine-deferiprone therapy

相似书籍

• Efficacy and safety of iron-chelation therapy with deferoxamine, deferiprone, and deferasirox for the treatment of iron-loaded patients with nontransfusion-dependent thalassemia syndromes
  由: Taher AT, et al.
  出版: (2016-12-01)
• Comparison of iron chelation effects of deferoxamine, deferasirox, and combination of deferoxamine and deferiprone on liver and cardiac T2* MRI in thalassemia maior
  由: Shahla Ansari, et al.
  出版: (2017-06-01)
• Continued improvement in cardiac T2*with deferasirox treatment over 2 years: Results from the extension of epic cardiac substudy in beta-thalassaemia patients with myocardial siderosis
  由: Pennell, D., et al.
  出版: (2010)
• Effects of combined deferiprone with deferoxamine on right ventricular function in thalassaemia major
  由: Alpendurada Francisco, et al.
  出版: (2012-01-01)
• Comparative Efficacy of Deferiprone, Deferoxamine and Combination of Deferiprone and Deferoxamine on Serum Ferritin Value in Beta-Thalassemia Patients
  由: Nargesbeygom Mirbehbahani, et al.
  出版: (2015-01-01)